Analysts/Institutional Investor Meet/Con. Call UpdatesNSE filing · raw filing ↗
14 Aug 2026
⚑ Filing
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call UpdatesNSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Windlas Biotech Ltd - 543329 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Recording Of Conference CallBSE filing · raw filing ↗
10 Aug 2026
⚑ Filing
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE filing · raw filing ↗
10 Aug 2026
⚑ Filing
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE filing · raw filing ↗
Q4 FY26 results filed — revenue ₹238 Cr (+17.7% YoY), PAT ₹16 Cr (−1.8% YoY)NSE filing · raw filing ↗
21 May 2026
⚑ Filing
Disclosure under SEBI Takeover RegulationsNSE filing · raw filing ↗
Ex-date 24 Apr 2026
⚑ Corp action
Buy BackNSE filing · record 24 Apr 2026
Ex-date 21 Jul 2025
⚑ Corp action
Dividend — ₹5.80 per shareNSE filing · record 21 Jul 2025
Ex-date 17 Sep 2024
⚑ Corp action
Dividend — ₹5.50 per shareNSE filing · record 17 Sep 2024
Ex-date 5 Sep 2023
⚑ Corp action
Dividend — ₹4.00 per shareNSE filing
Ex-date 9 Sep 2022
⚑ Corp action
Dividend — ₹3.50 per shareNSE filing
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
